期刊文献+

NTx在小细胞肺癌骨转移裸鼠模型中疗效的预测作用 被引量:2

Prognostic Effects of Serum Cross-linked N-telopeptide of Type Ⅰ Collagen in Skeletal Metastasis Model of Small Cell Lung Cancer
下载PDF
导出
摘要 目的探讨溶骨性骨代谢生化指标血Ⅰ型胶原交联氨基末端肽(cross-linked N-telopeptide oftypeⅠcollagen,NTx)的定量测定对肺癌骨转移治疗的意义。方法将18只Balb/c-nu/nu雄性裸鼠随机分成正常组、实验组和对照组。将人肺小细胞肺癌细胞株H446种植于实验组和对照组裸鼠右后肢胫骨,制成小细胞肺癌骨转移裸鼠动物模型,第一次服氯磷酸二钠前及处死前半小时各留血样1次,每1周测体重,观察存活情况,给药6周后处死裸鼠,所有裸鼠行放射学检查并取各裸鼠的右后肢行病理分析,用ELISA方法测定血清NTx水平。结果放射学及病理检查显示裸鼠接种H446细胞后引起明显的肿瘤性骨损伤。实验组、对照组裸鼠血清NTx高于正常组裸鼠血清NTx(P<0.01),实验组裸鼠经氯膦酸二钠治疗前后血清NTx水平差异有统计学意义(P<0.01)。结论定量测定NTx水平变化可用于预测氯膦酸二钠治疗小细胞肺癌骨转移的疗效。血清NTx对小细胞肺癌骨转移的诊断有重要参考意义,可协助及时诊断恶性肿瘤骨转移,且氯膦酸二钠可明显减轻小细胞肺癌骨转移程度。 Objective To establish a skeletal metastasis model of small cell lung cancer,and evaluate the prognosis role of serum cross-linked N-telopeptide of typeⅠcollagen(NTx) in disodium clodronate against skeletal metastasis.Methods A skeletal metastasis model was established by injection of small cell lung carcinoma line(SCLC) H446 cells and disodium clodronate was given to the animals once radiologically osteolytic metastasis was observed.Both X-ray and histological assay were applied to diagnose the bone metastasis.The levels of serum NTx were measured by using ELISA.Results Both X-ray and histological assay showed markedly bone injuries after injection cells into the right leg of nude mice.The level of serum NTx in the nude mice with bone metastasis was significantly higher than those without bone metastasis(P0.01),and it was also significantly different in the nude mice with disodium clodronate.Conclusion Serum NTx played a biomarker role of bone metastasis with malignant carcinoma through a timely diagnosis.Disodium clodronate might be an appropriate treatment of bone metastasis.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2011年第5期498-501,共4页 Cancer Research on Prevention and Treatment
关键词 Ⅰ型胶原交联氨基末端肽 小细胞肺癌 骨转移 NTx Small cell lung caner Skeletal metastasis
  • 相关文献

参考文献7

  • 1Corey E, Brown LG, Quinn JE, et al. Zoledronic acid exhibits inhibitory effects on osteoblastic and osteolytic metastases of prostate cancer[J]. Clin Cancer Res, 2003, 9(1 ) : 295-306.
  • 2Quint LE, Tumrnala S, Bressin LJ,et al. Distribution ofdistant metastases from newly diagnosed non-small-cell lung cancer [J]. Ann Thorac Surg, 1996,62(1 ): 246-250.
  • 3Hortobagyi GN, Theriault RL, Porter L, et al. Efficacy of pam-idranate in reducing skeletal complications in patients with breast cancer and lytic bone metastases[J]. N Engl J Med, 1996,33(5) : 1785-1791.
  • 4Body JJ, Bart IR, Burckhardt P, et al. Current use of bisphos- phonates in oneology[J]. J Clin Oncol, 1998, 16 (9) : 3890- 3899.
  • 5于世英.双膦酸盐在癌症骨转移治疗中的地位[J].中国处方药,2005,4(10):44-44. 被引量:1
  • 6Demers LM , Costa L , Chinchilli VM, et al. Biochemical markers of bone turnover in patients with metastatic bone dis- ease[J]. Clin Chem, 1995,41 (10) : 1489-1494.
  • 7Vinholes J J, Purohit OP, Abbey ME, et al. Relationship be- tween and symptomatic response in a doubleblind ranomized trial of pamidronate for metastatic bone disease[J]. Ann On- col, 1997,8(12) :1243-1250.

同被引文献23

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部